BIONDINI, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.523
AS - Asia 3.306
EU - Europa 1.925
SA - Sud America 545
AF - Africa 530
Continente sconosciuto - Info sul continente non disponibili 154
OC - Oceania 43
Totale 12.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.168
SG - Singapore 1.034
IT - Italia 767
CN - Cina 626
VN - Vietnam 371
BR - Brasile 348
HK - Hong Kong 329
BD - Bangladesh 207
IN - India 115
FR - Francia 111
DE - Germania 110
FI - Finlandia 106
CA - Canada 91
SE - Svezia 84
GB - Regno Unito 77
NL - Olanda 72
PL - Polonia 64
AR - Argentina 63
RU - Federazione Russa 58
TR - Turchia 57
BJ - Benin 53
IQ - Iraq 49
JP - Giappone 45
ZA - Sudafrica 42
ES - Italia 39
MX - Messico 38
PH - Filippine 37
KR - Corea 33
IE - Irlanda 31
ID - Indonesia 29
AT - Austria 28
PK - Pakistan 27
SA - Arabia Saudita 26
AL - Albania 25
CO - Colombia 23
CR - Costa Rica 23
EC - Ecuador 23
UZ - Uzbekistan 23
CI - Costa d'Avorio 22
CH - Svizzera 21
LB - Libano 21
VE - Venezuela 21
BY - Bielorussia 20
HU - Ungheria 20
UA - Ucraina 20
AE - Emirati Arabi Uniti 19
AU - Australia 19
BE - Belgio 19
JO - Giordania 19
SN - Senegal 19
AO - Angola 18
AZ - Azerbaigian 18
CZ - Repubblica Ceca 18
MU - Mauritius 18
CD - Congo 17
GE - Georgia 17
JM - Giamaica 17
ME - Montenegro 17
GT - Guatemala 16
LV - Lettonia 16
MD - Moldavia 16
MY - Malesia 16
NI - Nicaragua 16
PS - Palestinian Territory 16
TN - Tunisia 16
BB - Barbados 15
BG - Bulgaria 15
EG - Egitto 15
MA - Marocco 15
RO - Romania 15
TJ - Tagikistan 15
AM - Armenia 14
BF - Burkina Faso 14
GR - Grecia 14
KG - Kirghizistan 14
LY - Libia 14
PE - Perù 14
PR - Porto Rico 14
PT - Portogallo 14
PY - Paraguay 14
TH - Thailandia 14
BS - Bahamas 13
CL - Cile 13
LU - Lussemburgo 13
MZ - Mozambico 13
NP - Nepal 13
PA - Panama 13
BA - Bosnia-Erzegovina 12
CM - Camerun 12
ET - Etiopia 12
HN - Honduras 12
HR - Croazia 12
KE - Kenya 12
KH - Cambogia 12
LC - Santa Lucia 12
MW - Malawi 12
RE - Reunion 12
RS - Serbia 12
RW - Ruanda 12
BZ - Belize 11
Totale 11.407
Salva come PNG Salva come JPEG
Città #
Ashburn 815
San Jose 662
Singapore 639
Fairfield 511
Hong Kong 299
Woodbridge 273
Chandler 222
Houston 198
Seattle 181
Cambridge 170
Los Angeles 143
Beijing 136
Ho Chi Minh City 131
Wilmington 128
Santa Clara 112
Council Bluffs 111
Ann Arbor 103
Hanoi 91
New York 86
Boardman 68
Helsinki 62
Cotonou 52
Lauterbourg 49
Munich 48
San Diego 44
Padova 43
Orem 41
Dallas 38
Medford 38
São Paulo 38
Bytom 37
Chicago 37
Buffalo 35
Rome 35
Tokyo 34
Milan 33
Princeton 33
Hefei 29
Dublin 28
Roxbury 28
Da Nang 27
Turku 26
Des Moines 25
Frankfurt am Main 24
Johannesburg 24
Trieste 23
Baghdad 22
Tashkent 21
Toronto 20
Amman 19
Atlanta 19
Dakar 19
Montreal 19
Seoul 19
Abidjan 18
Chennai 18
London 18
Padua 18
Pune 18
Rio de Janeiro 17
Denver 16
Managua 16
Podgorica 16
San José 16
Baku 15
Bridgetown 15
Jinan 15
Vienna 15
Dong Ket 14
Kinshasa 14
Luanda 14
Pordenone 14
Bishkek 13
Dushanbe 13
Guangzhou 13
Mexico City 13
Phoenix 13
Tirana 13
Washington 13
Brooklyn 12
Castries 12
Guatemala City 12
Kigali 12
Kingston 12
Minsk 12
Ogden 12
Stockholm 12
Tbilisi 12
Warsaw 12
Ankara 11
Dhaka 11
Nanjing 11
Naples 11
Nassau 11
Panama City 11
Riga 11
San Francisco 11
Tianjin 11
Zurich 11
Chisinau 10
Totale 6.786
Salva come PNG Salva come JPEG
Nome #
From cigarette smoking to Chronic Obstructive Pulmonary Disease or Idiopathic Pulmonary Fibrosis. Why? 554
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies 347
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment 339
Critical review of the evolution of extracellular vesicles’ knowledge: From 1946 to today 326
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 293
Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity 289
Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease 289
A rejuvenation effect of the antifibrotic therapy correlates with lung function improvement in IPF patients 280
Immune inflammation and disease progression in idiopathic pulmonary fibrosis 279
Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing 274
CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline 272
Clinical and pathologic factors predicting future Asthma in wheezing children: A longitudinal study 271
Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department 263
High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology 258
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort Study 256
Deficient Immune Response to Viral Infections in Children Predicts Later Asthma Persistence 244
α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency 238
Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19 234
Blood eosinophils relate to atopy and not to tissue eosinophils in wheezing children 228
Alpha-1 antitrypsin deficiency today: New insights in the immunological pathways 227
Risk Factors for Development and Severity of COVID-19 in COPD Patients 225
Tertiary lymphoid structures and B-cell infiltration are IPF features with functional consequences 225
Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD) 223
Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) 223
Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease 220
The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis 220
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis 212
Do Circulating Extracellular Vesicles Strictly Reflect Bronchoalveolar Lavage Extracellular Vesicles in COPD? 210
Suppressor of cytokine signaling-3 expression and its regulation in relation to inflammation in Chronic Obstructive Pulmonary Disease 210
The role of bronchoscopy in the diagnosis and management of patients with sars-cov-2 infection 210
Symptomatic smokers without COPD have physiological changes heralding the development of COPD 207
Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD 206
Idiopathic pulmonary fibrosis and lung transplantation: When it is feasible 205
Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment 203
Clinical Applications of Endobronchial Ultrasound (EBUS) Scope: Challenges and Opportunities 198
Exome sequencing reveals immune genes as susceptibility modifiers in a1-antitrypsin deficiency 197
Endobronchial solitary fibrous tumors: An enigma for diagnosis 195
Extracellular Vesicles in Lung Cancer: Bystanders or Main Characters? 193
Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison? 190
Macrophages-derived Factor XIII links coagulation to inflammation in COPD 190
Unveiling the Cutting-Edge Impact of Polarized Macrophage-Derived Extracellular Vesicles and MiRNA Signatures on TGF-β Regulation within Lung Fibroblasts 187
Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial 185
Exome sequencing in diseased and healthy subjects with alpha-1 antitrypsin deficiency 182
What do we know about extracellular vesicles in patients with idiopathic pulmonary fibrosis? a scoping review 170
Editorial: New insights in sarcoidosis: from bench to bedside 170
Successful lung retransplantation in a patient with acute fibrinous and organizing pneumonia: A case report 160
Association between leukocyte telomere length (LTL) and functional decline in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic treatment 154
Pulmonary fibrosis secondary to COVID-19: a call to arms? 150
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey 138
Detection of lung allograft injury through a comprehensive multidisciplinary analysis of donor-derived cell-free DNA in plasma and bronchoalveolar lavage: a real-world single center experience 135
Herpes simplex virus 2 hepatitis in a lung transplant recipient: A diagnostic challenge 131
The clinical relevance of lymphocyte to monocyte ratio in patients with Idiopathic Pulmonary Fibrosis (IPF) 124
Long-Term Macrolides in Chronic Respiratory Diseases: Dusk or a New Dawn? A Narrative Review 85
Non-Specific Pleuritis After Medical Thoracoscopy: The Portrait of an Open Issue and Practical Hints for Its Management 81
Emphysema type-CLE or PLE- determines pulmonary arteries remodeling in COPD 51
Totale 12.026
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.846
article - articoli 30.853
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022612 0 26 112 46 68 34 18 90 76 11 27 104
2022/2023489 84 33 23 48 84 49 10 42 76 7 27 6
2023/2024461 10 52 49 29 40 86 26 37 22 35 38 37
2024/20251.509 49 115 90 65 137 64 96 115 128 68 262 320
2025/20266.702 329 448 733 974 623 326 1.017 579 698 337 359 279
2026/2027584 324 260 0 0 0 0 0 0 0 0 0 0
Totale 12.026